This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by exploring how experiential knowledge can complement professional and scientific knowledge and underscoring the benefits of incorporating experiential knowledge within the development of evidence-based care and support for people with intellectual disabilities.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by identifying barriers for individuals with ID, their impact on long-term outcomes, and strategies that academics can use to foster positive identity development for this population.
This content supports the SDG Goal 3: Good health and well-being by formulating an epidemiological mathematical model that demonstrates the transmission of the hepatitis B virus for use in research.
Elsevier,
Overcoming Obstacles in Drug Discovery and Development
Surmounting the Insurmountable—Case Studies for Critical Thinking
2023, Pages 215-222
This content aligns with Goal 3: Good Health and Wellbeing by identifying the reactive metabolite responsible for the species-specific nephrotoxicity observed in rats dosed with efavirenz provide a framework for addressing nonclinical toxicities and clinical risk and providing a solid scientific basis for regulatory review.
Ticks: Biology, Ecology, and Diseases, 2023, Pages 193-215
This chapter advances the UN SDG Goal 3: Good Health by covering the range of approaches to the control of tick and tick-borne diseases.
This content supports the SDG Goal 3: Good health and well-being by showing the the pathological consequences of infection with hepatotropic viruses.
This content supports the SDG Goal 3: Good health and well-being by providing information on Autoimmune hepatitis (AIH).
This content supports the SDG Goal 3: Good health and well-being by exploring the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
This content supports the SDG Goal 3: Good health and well-being by exploring the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
This chapter advances Goals 3 and 13 by explaining why CE philosophy should be considered in national policies to guide waste and environmental management efforts.
